Earnings Feed
Start Free
Home/Filings/4/0001140361-11-011226
4//SEC Filing

Dupree Thomas J 4

Accession 0001140361-11-011226

CIK 0000874716other
View on SEC.govCompany Profile

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 5:24 PM ET

Size

59.2 KB

Accession

0001140361-11-011226

Insider Transaction Report

Form 4
Period: 2011-02-17
IDEXX LABORATORIES INC /DEIDXX
Dupree Thomas J
Corporate Vice President
Transactions
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2011-02-17−14,942→ 1,704 total
    Exercise: $41.94Exp: 2014-02-13→ Common Stock (14,942 underlying)
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2011-02-17−1,728→ 0 total
    Exercise: $38.34Exp: 2013-02-13→ Common Stock (1,728 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2011-02-17−3,598→ 0 total
    Exercise: $38.34Exp: 2013-02-13→ Common Stock (3,598 underlying)
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2011-02-17−1→ 2,910 total
    Exercise: $34.37Exp: 2016-02-13→ Common Stock (1 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2011-02-17−6,016→ 0 total
    Exercise: $25.45Exp: 2014-02-04→ Common Stock (6,016 underlying)
  • Exercise/Conversion

    Common Stock

    2011-02-17$28.66/sh+3,780$108,316→ 37,063 total
  • Exercise/Conversion

    Common Stock

    2011-02-17$41.94/sh+14,942$626,593→ 62,635 total
  • Exercise/Conversion

    Common Stock

    2011-02-17$38.34/sh+3,598$137,929→ 67,961 total
  • Exercise/Conversion

    Common Stock

    2011-02-17$34.37/sh+8,299$285,237→ 88,085 total
  • Sale

    Common Stock

    2011-02-17$77.91/sh−17,930$1,396,887→ 73,989 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2011-02-17−14,600→ 0 total
    Exercise: $18.02Exp: 2013-03-10→ Common Stock (14,600 underlying)
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2011-02-17−1,410→ 2,384 total
    Exercise: $41.94Exp: 2014-02-13→ Common Stock (1,410 underlying)
  • Exercise/Conversion

    Common Stock

    2011-02-17$25.45/sh+6,984$177,743→ 27,267 total
  • Exercise/Conversion

    Common Stock

    2011-02-17$25.45/sh+6,016$153,107→ 33,283 total
  • Exercise/Conversion

    Common Stock

    2011-02-17$41.94/sh+1,410$59,128→ 47,693 total
  • Exercise/Conversion

    Common Stock

    2011-02-17$56.95/sh+1$57→ 67,962 total
  • Exercise/Conversion

    Common Stock

    2011-02-17$18.02/sh+14,600$263,165→ 20,283 total
  • Exercise/Conversion

    Common Stock

    2011-02-17$38.34/sh+1,728$66,243→ 64,363 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2011-02-17−6,984→ 0 total
    Exercise: $25.45Exp: 2014-02-04→ Common Stock (6,984 underlying)
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2011-02-17−3,780→ 0 total
    Exercise: $28.66Exp: 2015-02-02→ Common Stock (3,780 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2011-02-17−9,220→ 0 total
    Exercise: $28.66Exp: 2015-02-02→ Common Stock (9,220 underlying)
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2011-02-17−1→ 1,755 total
    Exercise: $56.95Exp: 2015-02-13→ Common Stock (1 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2011-02-17−11,823→ 6,127 total
    Exercise: $56.95Exp: 2015-02-13→ Common Stock (11,823 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2011-02-17−8,299→ 9,540 total
    Exercise: $34.37Exp: 2016-02-13→ Common Stock (8,299 underlying)
  • Exercise/Conversion

    Common Stock

    2011-02-17$28.66/sh+9,220$264,199→ 46,283 total
  • Exercise/Conversion

    Common Stock

    2011-02-17$56.95/sh+11,823$673,320→ 79,785 total
  • Exercise/Conversion

    Common Stock

    2011-02-17$34.37/sh+1$34→ 79,786 total
  • Exercise/Conversion

    Common Stock

    2011-02-17$53.31/sh+3,834$204,391→ 91,919 total
  • Sale

    Common Stock

    2011-02-17$77.72/sh−68,306$5,308,735→ 5,683 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2011-02-17−3,834→ 13,461 total
    Exercise: $53.31Exp: 2017-02-13→ Common Stock (3,834 underlying)
Footnotes (16)
  • [F1]The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $77.90 to $77.95, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
  • [F10]Grant of options to buy shares of common stock becomes exercisable as to 664 shares on 02/14/2010 and the remaining 1,064 shares on 02/14/2011.
  • [F11]Grant of options to buy shares of common stock becomes exercisable as to 1,066 shares on 02/14/2007, 02/14/2008, 02/14/2009, and the remaining 400 shares on 02/14/2010.
  • [F12]Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2011 and the remaining 1,755 shares on 02/14/2013.
  • [F13]Grant of options to buy shares of common stock becomes exercisable as to 3,942 shares on 02/14/2009, 3,941 shares on 02/14/2010 and 02/14/2012, 3,940 shares on 02/14/2011, and the remaining 2,186 shares on 02/14/2013.
  • [F14]Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2010 and 02/14/2013, and the remaining 2,909 shares on 02/14/2014.
  • [F15]Grant of options to buy shares of common stock becomes exercisable as to 4,149 shares on 02/14/2010 and 2/14/2013, 4,150 shares on 02/14/2011 and 02/14/2012, and the remaining 1,241 shares on 02/14/2014.
  • [F16]Grant of options to buy shares of common stock becomes exercisable as to 3,834 shares on 02/14/2011, 02/14/2012, 02/14/2013, 02/14/2014, and the remaining 1,959 shares on 02/14/2015.
  • [F2]The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $77.70 to $77.82, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
  • [F3]Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (03/10/2004) of the date of grant.
  • [F4]Grant of options to buy shares of common stock becomes exercisable as to 1,096 shares on 02/05/2005, 02/05/2006, 02/05/2007, 02/05/2008, and the remaining 2,600 shares on 02/05/2009.
  • [F5]Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (02/05/2005) of the date of grant.
  • [F6]Grant of options to buy shares of common stock becomes exercisable as to 1,180 shares on 02/03/2009 and the remaining 2,600 shares on 02/03/2010.
  • [F7]Grant of options to buy shares of common stock becomes exercisable as to 2,600 shares on 02/03/2006, 02/03/2007, 02/03/2008, and the remaining 1,420 shares on 02/03/2009.
  • [F8]Grant of options to buy shares of common stock becomes exercisable as to 1,410 shares on 02/14/2011 and the remaining 2,384 shares on 02/14/2012.
  • [F9]Grant of options to buy shares of common stock becomes exercisable as to 4,088 shares on 02/14/2008, 02/14/2009, 02/14/2010, 2,678 shares on 02/14/2011, and the remaining 1,704 shares on 02/14/2012.

Documents

1 file

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

→
Entity typeother

Related Parties

1
  • filerCIK 0001377233

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 5:24 PM ET
Size
59.2 KB
View on SEC.gov